KCM Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3M Sell
24,219
-807
-3% -$818K 0.74% 39
2025
Q4
$26.9M Buy
25,026
+90
+0.4% +$86.1K 0.86% 36
2025
Q3
$19M Buy
24,936
+3,059
+14% +$2.28M 0.61% 43
2025
Q2
$17.1M Sell
21,877
-15,873
-42% -$12.3M 0.57% 45
2025
Q1
$31.2M Buy
37,750
+331
+0.9% +$275K 1.12% 29
2024
Q4
$28.9M Sell
37,419
-1,249
-3% -$1.03M 1% 31
2024
Q3
$34.3M Buy
38,668
+394
+1% +$354K 1.16% 28
2024
Q2
$34.7M Buy
38,274
+83
+0.2% +$66.4K 1.24% 24
2024
Q1
$29.7M Sell
38,191
-41
-0.1% -$29.2K 1.1% 29
2023
Q4
$22.3M Buy
38,232
+1,950
+5% +$1.14M 0.89% 35
2023
Q3
$19.5M Buy
36,282
+3,848
+12% +$1.98M 0.84% 37
2023
Q2
$15.2M Buy
32,434
+6,960
+27% +$2.92M 0.61% 48
2023
Q1
$8.75M Buy
25,474
+2,573
+11% +$868K 0.35% 66
2022
Q4
$8.38M Buy
22,901
+22
+0.1% +$7.8K 0.36% 69
2022
Q3
$7.4M Sell
22,879
-1
-0% -$317 0.34% 70
2022
Q2
$7.42M Sell
22,880
-1,464
-6% -$439K 0.32% 73
2022
Q1
$6.97M Sell
24,344
-326
-1% -$83.9K 0.26% 86
2021
Q4
$6.81M Sell
24,670
-209
-0.8% -$53K 0.24% 92
2021
Q3
$5.75M Sell
24,879
-116
-0.5% -$28.6K 0.23% 93
2021
Q2
$5.74M Sell
24,995
-470
-2% -$94.4K 0.23% 94
2021
Q1
$4.76M Buy
25,465
+750
+3% +$147K 0.21% 98
2020
Q4
$4.17M Buy
24,715
+3,186
+15% +$476K 0.2% 101
2020
Q3
$3.19M Sell
21,529
-3,415
-14% -$529K 0.18% 102
2020
Q2
$4.09M Buy
24,944
+467
+2% +$71.7K 0.23% 86
2020
Q1
$3.4M Sell
24,477
-1,625
-6% -$223K 0.23% 87
2019
Q4
$3.43M Sell
26,102
-1,364
-5% -$158K 0.19% 102
2019
Q3
$3.07M Sell
27,466
-265
-1% -$29.5K 0.18% 108
2019
Q2
$3.07M Buy
27,731
+15
+0.1% +$1.77K 0.18% 106
2019
Q1
$3.6M Sell
27,716
-1,177
-4% -$143K 0.23% 98
2018
Q4
$3.34M Sell
28,893
-60
-0.2% -$6.7K 0.22% 100
2018
Q3
$3.11M Sell
28,953
-764
-3% -$76.4K 0.18% 111
2018
Q2
$2.54M Sell
29,717
-14,957
-33% -$1.23M 0.16% 132
2018
Q1
$3.46M Sell
44,674
-4,047
-8% -$326K 0.21% 108
2017
Q4
$4.12M Sell
48,721
-3,092
-6% -$263K 0.24% 102
2017
Q3
$4.43M Sell
51,813
-1,987
-4% -$163K 0.27% 98
2017
Q2
$4.43M Sell
53,800
-2,477
-4% -$202K 0.28% 94
2017
Q1
$4.73M Sell
56,277
-7,748
-12% -$621K 0.3% 88
2016
Q4
$4.71M Buy
64,025
+1,310
+2% +$97.6K 0.32% 88
2016
Q3
$5.03M Sell
62,715
-1,180
-2% -$94.4K 0.34% 84
2016
Q2
$5.03M Buy
63,895
+1,395
+2% +$105K 0.35% 83
2016
Q1
$4.5M Sell
62,500
-276
-0.4% -$20.9K 0.33% 90
2015
Q4
$5.29M Buy
62,776
+925
+1% +$76.8K 0.42% 70
2015
Q3
$5.18M Buy
61,851
+3,551
+6% +$300K 0.43% 69
2015
Q2
$4.87M Buy
58,300
+4,114
+8% +$313K 0.39% 76
2015
Q1
$3.94M Sell
54,186
-1,007
-2% -$71.7K 0.32% 95
2014
Q4
$3.81M Buy
55,193
+7,883
+17% +$532K 0.32% 92
2014
Q3
$3.07M Sell
47,310
-1,689
-3% -$107K 0.28% 103
2014
Q2
$3.05M Buy
48,999
+14,476
+42% +$864K 0.28% 107
2014
Q1
$2.03M Buy
34,523
+12,699
+58% +$709K 0.21% 134
2013
Q4
$1.11M Sell
21,824
-605
-3% -$30.3K 0.12% 202
2013
Q3
$1.13M Buy
22,429
+1,215
+6% +$63.6K 0.13% 184
2013
Q2
$1.04M Buy
+21,214
New +$1.15M 0.13% 193

Other funds holding LLY

KCM Investment Advisors's LLY Position: Q1 2026 in Review

KCM Investment Advisors reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $818K and leaving 24,219 shares worth $22.3M. The position accounts for 0.74% of the portfolio, ranked #39.

KCM Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.7M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • KCM Investment Advisors held 24,219 shares of Eli Lilly worth $22.3M as of Q1 2026.
  • KCM Investment Advisors sold 807 Eli Lilly shares in Q1 2026, an estimated $818K.
  • Eli Lilly made up 0.74% of KCM Investment Advisors's portfolio in Q1 2026, its #39 holding.
  • KCM Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • KCM Investment Advisors's Eli Lilly position peaked at $34.7M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on KCM Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.